Healthcare & Life Sciences
Replay
seed
seed
Stage
2
Investors
About
Replay develops a platform for delivering large DNA payloads efficiently to a variety of cell types, including a high-capacity HSV vector for gene delivery and a hypoimmunogenic iPSC therapeutic platform to advance cell and gene therapies.
Explore Replay's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.